Gevo (NASDAQ:GEVO) CEO Patrick Gruber sold 7,310 shares of the company’s stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $0.81, for a total value of $5,921.10. Following the transaction, the chief executive officer now directly owns 394,712 shares of the company’s stock, valued at approximately $319,717. The sale was disclosed in a legal filing with the SEC, which is available at this link.
A number of analysts have recently weighed in on GEVO shares. Analysts at Zacks upgraded shares of Gevo from a “neutral” rating to an “outperform” rating in a research note on Wednesday, April 9th. They now have a $1.50 price target on the stock. Analysts at Cowen and Company reiterated a “market perform” rating on shares of Gevo in a research note on Wednesday, March 26th.
Shares of Gevo (NASDAQ:GEVO) traded up 12.45% on Friday, hitting $0.93. 1,564,809 shares of the company’s stock traded hands. Gevo has a 52 week low of $0.73 and a 52 week high of $2.32. The stock’s 50-day moving average is $1.24 and its 200-day moving average is $1.42. The company’s market cap is $46.3 million.
Gevo (NASDAQ:GEVO) last posted its quarterly earnings results on Tuesday, March 25th. The company reported ($0.35) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.34) by $0.01. The company had revenue of $1.70 million for the quarter, compared to the consensus estimate of $1.46 million. During the same quarter in the prior year, the company posted ($0.34) earnings per share. The company’s quarterly revenue was down 10.5% on a year-over-year basis. Analysts expect that Gevo will post $-0.86 EPS for the current fiscal year.
Gevo, Inc, is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products.
Receive News & Ratings for Gevo Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.